PAM SQUARED AT BEAUMONT — History
CCN 453048 | 3-year financial timeline | COVID resilience: 23/100
🛡️ Public data only — no PHI permitted on this instance.
$13M
Latest Revenue (FY2022)
-8.1%
Revenue CAGR (3yr)
-5.9%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $15M | $15M | $13M | -15.0% | -8.1% |
| Operating Expenses | $13M | $15M | $14M | -5.0% | +3.8% |
| Operating Margin | 17.0% | 5.3% | -5.9% | -210.7% | +0.0% |
| Net Income | $3M | $1M | $-1M | -194.0% | +0.0% |
| Licensed Beds | 61 | 61 | 61 | +0.0% | +0.0% |
| Total Patient Days | 8,717 | 8,225 | 7,209 | -12.4% | -9.1% |
| Medicare Day % | 63% | 61% | 60% | -1.4% | -2.4% |
| Medicaid Day % | nan% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 23/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -15.5% ($15M → $13M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-8.1%
This Hospital
+7.6%
State Avg
Latest Margin
-5.9%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $12M | -17.3% |
| FY2024 (proj) | $11M | -28.8% |
| FY2025 (proj) | $9M | -40.2% |